Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_assertion type Assertion NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_head.
- NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_assertion description "[Furthermore, in clinical stages I and II, hypermethylation in RAR-beta (67%) and FHIT (78%) was frequently detected, whereas no VHL hypermethylation and 11% of RASSF1A hypermethylation were detected.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_provenance.
- NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_assertion evidence source_evidence_literature NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_provenance.
- NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_assertion SIO_000772 12839965 NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_provenance.
- NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_assertion wasDerivedFrom befree-2016 NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_provenance.
- NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_assertion wasGeneratedBy ECO_0000203 NP400327.RARTqe3pltABrt3NjLkwEb0F3EiGpP-93asVt1XynlpfY130_provenance.